Mellstedt, Håkan *

Seminar Title: 


Karolinska Institute, Stockholm



1. Current Status, Position

Mr Mellstedt is Professor of Oncologic Biotherapy at the Karolinska Institute, CancerCentre Karolinska at the Karolinska University Hospital Solna, Stockholm.

2. Education

  • 1996-1999: MD, PhD at the Karolinska Institute, Professor of Experimental Oncology at Uppsala University and Academic Hospital.
  • Since 1999: Professor of Oncologic Biotherapy at Karolinska Insitute.
  • Board certified in Internal Medicine, Hematology and Oncology.
  • 2004-2009: ESMO President.

3. Research Area

  • Immune biology of B-lymphoproliferative diseases and gastrointestinal cancer. 
  • Development of monoclonal antibody therapy and cancer vaccine in malignant B-cell disorders, colorectal and pancreatic carcinoma. 
  • Development of therapeutic monoclonal antibodies and thyrosine kinase receptors against the RTK ROR. 
  • He has published more than 500 scientific articles within these areas and written numerous chapters in text books.
Conflict of interest: Håkan Mellstedt has received honoraria from Abbvie, Amgen, Bio-Sweden, Boeringer-Ingelheim, Hospira, Roche and research grants from Merck GmBH.
Håkan Mellstedt has served on ad hoc SAB for Abbvie, Amgen, Boeringer-Ingelheim, Hospira.